Sarepta Therapeutics Inc Dividends
The next dividend date for Sarepta Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Sarepta Therapeutics Inc (SRPT)
More About Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Owning Sarepta Therapeutics Inc Stock on the Dividend Date
If you own Sarepta Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Sarepta Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Sarepta Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Sarepta Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Sarepta Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Sarepta Therapeutics Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Sarepta Therapeutics Inc stock price from the dividend is already baked into Sarepta Therapeutics Inc option prices.
That means the prices of call options that overlap the Sarepta Therapeutics Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Sarepta Therapeutics Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Sarepta Therapeutics Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Sarepta Therapeutics Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Sarepta Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about Sarepta Therapeutics Inc dividends or anything else related to the stock market.